Bristol Myers Squibb (BMS) approached Brillio Design to revamp their website Bolder Science. This site serve as an educational and informational hub, featuring high-quality scientific content on clinical trials. Client wanted to have a website with a delightful, modern experience while adhering to their brand guidelines.
MY ROLE
Responsible for research, conceptualization, low-fidelity designs
THE TEAM
2 UX Designers, 1 Visual Designer, 1 Principal Designer
TIMELINE
8 weeks
April – May 2024
ABOUT THE CLIENT
BMS is an american multinational biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.
![](https://apurva188.com/wp-content/uploads/2024/06/bms-logo-1024x335.jpg)
OVERVIEW OF THE PRODUCT
What are clinical trials?
Research studies that involve volunteers helping to determine if a new treatment (drug, diet, medical device, surgical procedure) or prevention is safe and effective in people.
What is the product’s vision?
There are over 400,000 registered trials on ClinicalTrials.gov. But their interface is outdated and there wasn’t a destination to be able to find clinical trials outside of ClinicalTrials.gov.
BMS launched BMS Science and Bolder Science in 2021, together for a comprehensive, easy, and customized search experience to find clinical trials.
![](https://apurva188.com/wp-content/uploads/2024/06/BMS_HomePage2-scaled.jpg)
Bolder Science HomePage
What is the difference between BMS Science & Bolder Science?
BMS Science and Bolder Science are structurally similar. Both source data from ClinicalTrials.gov. However,
BMS-sponsored trials: While BMS Science is dedicated to trials sponsored by BMS, Bolder Science encompasses trials from various sources including other companies and individual researchers. Essentially, the difference lies in the sample size of trials on both websites.
Molecular Pathways: It gives information on BMS’s current research pathways
USERS
Who are the users of Bolder Science?
![](https://apurva188.com/wp-content/uploads/2024/07/BMS_User-Photo-2.png)
Healthcare professionals (HCPs) are the users of these websites. They work with industries to benefit patients. They attend medical conferences and exchange information about clinical trials with drug and device developers. Further, they refer their patients to appropriate studies.
How do users discover the platform?
BMS showcases its platform at congress exhibits, where HCPs learn about it and then visit the platform.
PROBLEMS IDENTIFIED
What are the problems to solve for?
The platform has been losing its relevance for a long time. Users are not spending enough time engaging with content and interacting with multiple features. Here’s why:
- Minimal engagement on the platform – The average session duration is 2 min 12 sec and the bounce rate is 43.29% despite being a content hub
- Poor search experience – Search logic is limited considering the varied query types used, and it lacks personalization
- Challenges in finding the trial of interest – multi-step process to use filters, and large trial cards require excessive scrolling in search results
- No sense of belonging to the platform – Users do not sign up, resulting in an insignificant 1.35% of repeat users
- Poor visibility, complexity, unawareness of platform features – Suboptimal use of customization features like My Preferred Trials, My Saved Trials, and Saved Filters
- Issues with the site’s usability – Friction in the experience, slow loading time, poor navigation, unappealing design with inconsistency